Effect of formulation and process variables on the release behavior of amoxicillin matrix tablets.
The sustained release of amoxicillin is desired to be confined to the upper gastrointestinal tract to treat certain kind of infections. In vitro dissolution, at pH 1.2, of amoxicillin sustained release tablets has been studied varying the proportion of Carbopol 971P NF and sodium alginate as well as the ethanol/water proportion in the granulation fluid. M(t), the amount of drug released at time (t) and defined in terms of the total drug released over a long time period (M(inf), was described by M(t)/M(inf) = kt(n). Matrices with increasing proportions of sodium alginate showed increasing values of the exponent indicative of the release mechanism (n) and increasing release constant values (k). This is attributed to a drop in the coherence of the polymeric matrix with increasing alginate proportions that produces an increasing polymer relaxation and erosion. Decreasing Carbopol 971P NF proportions reduce the amount of dissolved polymer during granulation, producing a lesser obstruction of amoxicillin dissolution. Alginate proportions of 80% produce near zero order release profiles. Granules obtained with increasing ethanol proportions showed increasing release constant values and a minor change in the exponent (n) values. This is considered a result of lower polymer dissolution during granulation that allows a lesser matrix coherence and a greater amoxicillin dissolution. Alginate matrices granulated with different ethanol/water proportions showed no significant changes in the amoxicillin release profile. There is a trend toward increasing floating times with increasing Carbopol 971P NF proportions.
Tapia-Albarran
Manuel
M
Departamento de Farmacia de la Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional de México, Distrito Federal, México.
Villafuerte-Robles
Leopoldo
L
D000179:Acrylates / Q000737:chemistry / Q000493:pharmacokinetics; D000464:Alginates / Q000737:chemistry / Q000493:pharmacokinetics; D000658:Amoxicillin / Q000493:pharmacokinetics*; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D003692:Delayed-Action Preparations / Q000493:pharmacokinetics; D016503:Drug Delivery Systems / Q000379:methods*; D020723:Glucuronic Acid / Q000737:chemistry / Q000493:pharmacokinetics; D006603:Hexuronic Acids / Q000737:chemistry / Q000493:pharmacokinetics; D006863:Hydrogen-Ion Concentration; D010316:Particle Size; D012995:Solubility; D013607:Tablets / Q000008:administration & dosage / Q000493:pharmacokinetics*; D013678:Technology, Pharmaceutical / Q000379:methods; D013997:Time Factors; D014783:Viscosity; D014867:Water
D000179:Acrylates; D000464:Alginates; D003692:Delayed-Action Preparations; D006603:Hexuronic Acids; D013607:Tablets; C117167:carbopol 974P NF; D014867:Water; D000658:Amoxicillin; D020723:Glucuronic Acid